Chemerin and IL-6 Levels in Diabetes and Periodontitis

NCT02596581 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2015-11-04

No results posted yet for this study

Summary

The aims of the present study were to determine the gingival crevicular fluid (GCF) chemerin and interleukin-6 (IL-6) levels and to analyse the relationship between chemerin and IL-6 in periodontal health and in chronic periodontitis (CP) with and without type 2 diabetes mellitus (T2DM) as well as to evaluate the effect of non-surgical periodontal therapy on the GCF chemerin levels.

Conditions

Interventions

OTHER

non-surgical periodontal treatment

scaling and root planing were performed

Sponsors & Collaborators

  • Bulent Ecevit University

    lead OTHER

Principal Investigators

  • Umut Ballı, Phd, DDS · Bülent Ecevit University Faculty of Dentistry

  • Figen Öngöz Dede, Phd, DDS · Bülent Ecevit University Faculty of Dentistry

  • Şeyma Bozkurt Doğan, Phd, DDS · Bülent Ecevit University Faculty of Dentistry

  • Erdim Sertoğlu, MD, DDS · Elazig Military Hospital, Department of Medical Biochemistry, Elazığ, Turke

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2015-05-31
Completion
2015-10-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02596581 on ClinicalTrials.gov